Literature DB >> 11333270

A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription.

M L Matter1, E Ruoslahti.   

Abstract

Integrin-mediated cell adhesion is necessary for the survival of many cell types, and loss of adhesion causes apoptosis. We have previously shown that the alpha5beta1 integrin supports cell survival on fibronectin and increases Bcl-2 protein expression. Here we show that bcl-2 transcription is elevated in cells that attach to fibronectin through alpha(v)beta1 or to vitronectin through alpha(v)beta3 but is not elevated in cells attaching through the alpha(v)beta1 integrin. Bcl-2 protein expression and protection from apoptosis under serum-free conditions correlated with bcl-2 transcription. This integrin-mediated regulation of bcl-2 is Shc- and FAK-dependent, and activation of Ras by FAK is required. Furthermore, Ras mediates this up-regulation of bcl-2 by activating the phosphatidylinositol 3-kinase-AKT pathway. Mitogen-activated protein kinase did not appear to be necessary for the activation of bcl-2 transcription. Therefore, our work characterizes the pathway that mediates the effect of integrins on bcl-2 transcription and cell survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333270     DOI: 10.1074/jbc.M102014200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Integrins in invasive growth.

Authors:  Cord Brakebusch; Daniel Bouvard; Fabio Stanchi; Takao Sakai; Reinhard Fässler
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Regulation of apoptosis by Bcl-2 family proteins.

Authors:  Alexandrina Burlacu
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

3.  Recombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosis.

Authors:  Cletus Cheyuo; Asha Jacob; Rongqian Wu; Mian Zhou; Lei Qi; Weifeng Dong; Youxin Ji; Wayne W Chaung; Haichao Wang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Neuropharmacology       Date:  2011-09-24       Impact factor: 5.250

Review 4.  Mesenchymal stem cells as cellular vectors for pediatric neurological disorders.

Authors:  Donald G Phinney; Iryna A Isakova
Journal:  Brain Res       Date:  2014-05-22       Impact factor: 3.252

Review 5.  Death and inflammation following somatic cell transplantation.

Authors:  Ian B Copland; Jacques Galipeau
Journal:  Semin Immunopathol       Date:  2011-05-01       Impact factor: 9.623

Review 6.  Targeting integrins to promote bone formation and repair.

Authors:  Pierre J Marie
Journal:  Nat Rev Endocrinol       Date:  2013-01-29       Impact factor: 43.330

7.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

8.  Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.

Authors:  Rika Tanaka; Yutaka Seki; Yohei Saito; Sadahiro Kamiya; Motomichi Fujita; Hiroaki Okutsu; Takuya Iyoda; Tatsuya Takai; Toshiyuki Owaki; Hirofumi Yajima; Junichi Taira; Ryo Hayashi; Hiroaki Kodama; Takuya Matsunaga; Fumio Fukai
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

Review 9.  Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy.

Authors:  G Chometon; V Jendrossek
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

10.  An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression.

Authors:  Jay S Desgrosellier; Leo A Barnes; David J Shields; Miller Huang; Steven K Lau; Nicolas Prévost; David Tarin; Sanford J Shattil; David A Cheresh
Journal:  Nat Med       Date:  2009-09-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.